EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

Speaker(s):

• David R. Jayne, Department of Medicine, University of Cambridge
• Peter A. Merkel, Division of Rheumatology, University of Pennsylvania
• Annette Bruchfeld, Linköping University, Karolinska Institutet
• Duvuru Geetha, Johns Hopkins
• Alexandre Karras, Hôpital Européen Georges-Pompidou
• John Niles, Massachusetts General Hospital
• Pirow Bekker, ChemoCentryx, Inc.